Valneva SE (INRLF)
OTCMKTS
· Delayed Price · Currency is USD
3.100
0.00 (0.00%)
Jul 2, 2025, 4:00 PM EDT
Valneva SE Employees
Valneva SE had 713 employees as of December 31, 2024. The number of employees increased by 37 or 5.47% compared to the previous year.
Employees
713
Change (1Y)
37
Growth (1Y)
5.47%
Revenue / Employee
$282,047
Profits / Employee
-$121,861
Market Cap
496.89M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo, Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Tian'an Technology Group | 8 |
Glass House Brands | 374 |
American Oncology Network | 1,914 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 116 |
Valneva SE News
- 26 days ago - UK's MHRA suspends Valneva's chikungunya vaccine for elderly - Reuters
- 4 weeks ago - Valneva's Chikungunya Vaccine Advances With Pediatric Trial, Phase 3 In 2026 - Benzinga
- 4 weeks ago - Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ® - GlobeNewsWire
- 4 weeks ago - Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - Valneva to Participate at U.S. and European Investor Conferences in June - GlobeNewsWire
- 7 weeks ago - Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States - GlobeNewsWire
- 2 months ago - Valneva SE (VALN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Valneva SE 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha